scholarly journals “Meds-in-Hand” Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis

Author(s):  
Rachel L Epstein ◽  
Nicole Penwill ◽  
Diana F Clarke ◽  
Sebastian Hamilton ◽  
Kevin Horbowicz ◽  
...  

Abstract Pediatric human immunodeficiency virus post-exposure prophylaxis is frequently indicated, but delays in medication receipt are common. Using plan-do-study-act cycles, we developed a multidisciplinary collaboration to reduce critical process delays in our pediatric emergency department. Interruptions decreased from a median 1 per month pre-intervention to zero per month during the intervention.

Author(s):  
P. Jabalin Mahiba

Post exposure prophylaxis (PEP) also known as post exposure prevention is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. Exposure to blood or body fluid prompts most people to seek immediate medical attention in an emergency department. These exposure have an associated risk of hepatitis B, hepatitis C and human immunodeficiency virus. Post exposure prophylaxis should be used only in emergency situation and must be started with in 72 hrs after a recent possible exposure to infection.


Sign in / Sign up

Export Citation Format

Share Document